Apremilast Versus Placebo for Genital Erosive Lichen Planus in Women: A Randomized Controlled Trial
Although having a small sample size, this randomized controlled trial did not reveal any signals indicating a clinical effect from apremilast treatment in women with moderate-to-severe GELP.
Authors
- Anne Lise Ording Helgesen
- Are Hugo Pripp (ORCID: https://orcid.org/0000-0002-1678-7309)
- Siri Vangen (ORCID: https://orcid.org/0000-0003-4681-4774)
- Petter Gjersvik (ORCID: https://orcid.org/0000-0002-3596-9829)
- Kristin Helene Skullerud (ORCID: https://orcid.org/0000-0002-6945-775X)
- Erik Qvigstad
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- NORCE Research AS (NO)
Publication Details
- Journal
- Journal of Lower Genital Tract Disease
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1097/lgt.0000000000000915
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00